179 related articles for article (PubMed ID: 24559177)
1. "Home is where the patient is": a qualitative analysis of a patient-centred model of care for multi-drug resistant tuberculosis.
Horter S; Stringer B; Reynolds L; Shoaib M; Kasozi S; Casas EC; Verputten M; du Cros P
BMC Health Serv Res; 2014 Feb; 14():81. PubMed ID: 24559177
[TBL] [Abstract][Full Text] [Related]
2. Where there is hope: a qualitative study examining patients' adherence to multi-drug resistant tuberculosis treatment in Karakalpakstan, Uzbekistan.
Horter S; Stringer B; Greig J; Amangeldiev A; Tillashaikhov MN; Parpieva N; Tigay Z; du Cros P
BMC Infect Dis; 2016 Jul; 16():362. PubMed ID: 27465783
[TBL] [Abstract][Full Text] [Related]
3. Person-centred care in practice: perspectives from a short course regimen for multi-drug resistant tuberculosis in Karakalpakstan, Uzbekistan.
Horter S; Stringer B; Gray N; Parpieva N; Safaev K; Tigay Z; Singh J; Achar J
BMC Infect Dis; 2020 Sep; 20(1):675. PubMed ID: 32938422
[TBL] [Abstract][Full Text] [Related]
4. Development of a Patient-Centred, Psychosocial Support Intervention for Multi-Drug-Resistant Tuberculosis (MDR-TB) Care in Nepal.
Khanal S; Elsey H; King R; Baral SC; Bhatta BR; Newell JN
PLoS One; 2017; 12(1):e0167559. PubMed ID: 28099475
[TBL] [Abstract][Full Text] [Related]
5. Patient and health-care provider experience of a person-centred, multidisciplinary, psychosocial support and harm reduction programme for patients with harmful use of alcohol and drug-resistant tuberculosis in Minsk, Belarus.
Harrison RE; Shyleika V; Falkenstein C; Garsevanidze E; Vishnevskaya O; Lonnroth K; Sayakci Ö; Sinha A; Sitali N; Skrahina A; Stringer B; Tan C; Mar HT; Venis S; Vetushko D; Viney K; Vishneuski R; Carrion Martin AI
BMC Health Serv Res; 2022 Sep; 22(1):1217. PubMed ID: 36180873
[TBL] [Abstract][Full Text] [Related]
6. Developing a patient-centered community-based model for management of multi-drug resistant tuberculosis in Uganda: a discrete choice experiment.
Makabayi-Mugabe R; Musaazi J; Zawedde-Muyanja S; Kizito E; Namwanje H; Aleu P; Charlet D; Freitas Lopez DB; Brightman H; Turyahabwe S; Nkolo A
BMC Health Serv Res; 2022 Feb; 22(1):154. PubMed ID: 35123467
[TBL] [Abstract][Full Text] [Related]
7. Improving outcomes for multi-drug-resistant tuberculosis in the Peruvian Amazon - a qualitative study exploring the experiences and perceptions of patients and healthcare professionals.
McNally TW; de Wildt G; Meza G; Wiskin CMD
BMC Health Serv Res; 2019 Aug; 19(1):594. PubMed ID: 31438958
[TBL] [Abstract][Full Text] [Related]
8. "I can also serve as an inspiration": a qualitative study of the TB&Me blogging experience and its role in MDR-TB treatment.
Horter S; Stringer B; Venis S; du Cros P
PLoS One; 2014; 9(9):e108591. PubMed ID: 25251404
[TBL] [Abstract][Full Text] [Related]
9. Hospitalized care for MDR-TB in Port Harcourt, Nigeria: a qualitative study.
Bieh KL; Weigel R; Smith H
BMC Infect Dis; 2017 Jan; 17(1):50. PubMed ID: 28068907
[TBL] [Abstract][Full Text] [Related]
10. "My Favourite Day Is Sunday": Community Perceptions of (Drug-Resistant) Tuberculosis and Ambulatory Tuberculosis Care in Kara Suu District, Osh Province, Kyrgyzstan.
Burtscher D; Van den Bergh R; Toktosunov U; Angmo N; Samieva N; Rocillo Arechaga EP
PLoS One; 2016; 11(3):e0152283. PubMed ID: 27019454
[TBL] [Abstract][Full Text] [Related]
11. Cost-consequence analysis of ambulatory clinic- and home-based multidrug-resistant tuberculosis management models in Eswatini.
Peresu E; De Graeve D; Heunis JC; Kigozi NG
PLoS One; 2024; 19(4):e0301507. PubMed ID: 38564589
[TBL] [Abstract][Full Text] [Related]
12. Pathways to multidrug-resistant tuberculosis diagnosis and treatment initiation: a qualitative comparison of patients' experiences in the era of rapid molecular diagnostic tests.
Naidoo P; van Niekerk M; du Toit E; Beyers N; Leon N
BMC Health Serv Res; 2015 Oct; 15():488. PubMed ID: 26511931
[TBL] [Abstract][Full Text] [Related]
13. Task-shifting directly observed treatment and multidrug-resistant tuberculosis injection administration to lay health workers: stakeholder perceptions in rural Eswatini.
Peresu E; Heunis JC; Kigozi NG; De Graeve D
Hum Resour Health; 2020 Dec; 18(1):97. PubMed ID: 33272307
[TBL] [Abstract][Full Text] [Related]
14. Multidrug-resistant tuberculosis outbreak associated with poor treatment adherence and delayed treatment: Arua District, Uganda, 2013-2017.
Okethwangu D; Birungi D; Biribawa C; Kwesiga B; Turyahabwe S; Ario AR; Zhu BP
BMC Infect Dis; 2019 May; 19(1):387. PubMed ID: 31064332
[TBL] [Abstract][Full Text] [Related]
15. Financial barriers and coping strategies: a qualitative study of accessing multidrug-resistant tuberculosis and tuberculosis care in Yunnan, China.
Hutchison C; Khan MS; Yoong J; Lin X; Coker RJ
BMC Public Health; 2017 Feb; 17(1):221. PubMed ID: 28222724
[TBL] [Abstract][Full Text] [Related]
16. Addressing the drug-resistant tuberculosis challenge through implementing a mixed model of care in Uganda.
Kasozi S; Kirirabwa NS; Kimuli D; Luwaga H; Kizito E; Turyahabwe S; Lukoye D; Byaruhanga R; Chen L; Suarez P
PLoS One; 2020; 15(12):e0244451. PubMed ID: 33373997
[TBL] [Abstract][Full Text] [Related]
17. Patient satisfaction with directly observed treatment and multidrug-resistant tuberculosis injection administration by lay health workers in rural Eswatini.
Peresu E; Heunis CJ; Kigozi GN; De Grave D
Afr J Prim Health Care Fam Med; 2020 May; 12(1):e1-e10. PubMed ID: 32501027
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and factors associated with non-adherence to multi-drug resistant tuberculosis (MDR-TB) treatment at Mulago National Referral Hospital, Kampala, Uganda.
Batte C; Namusobya MS; Kirabo R; Mukisa J; Adakun S; Katamba A
Afr Health Sci; 2021 Mar; 21(1):238-247. PubMed ID: 34394303
[TBL] [Abstract][Full Text] [Related]
19. Optimising recruitment to a late-phase tuberculosis clinical trial: a qualitative study exploring patient and practitioner experiences in Uzbekistan.
Wharton-Smith A; Horter S; Douch E; Gray N; James N; Nyang'wa BT; Singh J; Nusratovna PN; Tigay Z; Kazounis E; Allanazarova G; Stringer B
Trials; 2021 Dec; 22(1):881. PubMed ID: 34863253
[TBL] [Abstract][Full Text] [Related]
20. A qualitative evaluation of hospital versus community-based management of patients on injectable treatments for tuberculosis.
Cohen DB; Phiri M; Banda H; Squire SB; Namakhoma I; Desmond N
BMC Public Health; 2018 Sep; 18(1):1127. PubMed ID: 30223808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
